Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Transgene Biotek: The Board Has Considered And Approved The Unaudited Consolidated & Standalone Financial Results Of The Company For The Quarter Ended 31.12.2024 In Accordance With The Indian Accounting Standards (IND-AS) As Per Companies (Indian Accounting Standards) Rules 2015.Limited Review Report On The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended 31.12.2024 Has Also Been Approved.
News Announcement

Transgene Biotek: The Board Has Considered And Approved The Unaudited Consolidated & Standalone Financial Results Of The Company For The Quarter Ended 31.12.2024 In Accordance With The Indian Accounting Standards (IND-AS) As Per Companies (Indian Accounting Standards) Rules 2015.Limited Review Report On The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended 31.12.2024 Has Also Been Approved.

24-Jan-2025 Follow Value Research Online on Google download pdfDownload PDF Transgene Biotek

Financial Results 31-12-2024.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds